Saturday 17 October 2026
Export NRC’s income statement to Excel — free account
National Research Corporation
NRC Healthcare Health Information Services
National Research Corporation’s revenue for fiscal 2025 (year ended December 2025) was $137.4 million, down 3.96% from fiscal 2024. In the quarter to June 2026, revenue grew 3.98%, EPS fell 3,091.5%, free cash flow grew 101.5% and total debt rose 11.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years; insiders bought in the last twelve months.
20.15
0.96
−4.55%
Follow NRC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 39.82% | 40.43% | 49.88% | 66.87% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 6 | 6 | |
| 4.00% | 6.47% | 8.45% | 12.23% | ||
ROIC |
10.32% | 14.39% | 16.64% | 19.51% | |
Return on Tangible Assets |
20.34% | 40.00% | 46.93% | 70.38% | |
Average Days of Receivables |
35.59 | 29.79 | 30.91 | 33.45 | |
Free Cash Flow per Share |
0.98 | 0.80 | 0.70 | 0.53 | |
Free Cash Flow |
21.64 | 17.43 | 15.74 | 11.62 | |
Capital Expenditures |
(7.87) | (9.55) | (10.71) | (14.03) | |
| Other line items | |||||
Cash ROIC |
22.57% | 19.35% | 16.90% | 12.56% | |
Accounts Receivable Turnover |
10.56 | 12.17 | 12.04 | 11.38 | |
Accounts Payable Turnover |
42.74 | 24.88 | 44.33 | 28.67 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
9.04 | 15.35 | 8.15 | 7.56 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.38) | (0.38) | (0.35) | (0.30) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
45.06% | 41.74% | 39.89% | 37.25% | |
Share Based Compensation of Revenue |
8.44% | 3.43% | 2.41% | 1.14% | |
Interest Coverage |
2.73 | 3.82 | 4.74 | 6.68 | |
Operating CF/Net income |
5.32 | 3.09 | 2.34 | 1.57 | |
Depreciation/Fixed assets |
0.22 | 0.21 | 0.19 | 0.17 | |
Capex/Depreciation |
(0.90) | (1.14) | (1.39) | (1.98) | |
Revenue per Share |
6.36 | 6.36 | 6.14 | 6.29 | |
Operating CF per Share |
1.34 | 1.24 | 1.18 | 1.16 | |
Capex per Share |
(0.36) | (0.44) | (0.48) | (0.63) | |
Capex to Sales |
0.06 | 0.07 | 0.08 | 0.10 |
Columns are period end dates